Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.25 USD | -2.94% | +5.23% | -0.48% |
09/05 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
08/05 | LifeMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.48% | 36Cr | |
-9.49% | 3.14TCr | |
+25.35% | 833.22Cr | |
+33.25% | 427.19Cr | |
-35.85% | 246.9Cr | |
-9.44% | 164.74Cr | |
-13.39% | 149.94Cr | |
-32.84% | 107.23Cr | |
+7.80% | 97Cr | |
-37.56% | 84Cr |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- Earnings Flash (LFMD) LIFEMD Posts Q2 Revenue $35.9M, vs. Street Est of $35.2M